Antidyskinetic Treatment with MTEP Affects Multiple Molecular Pathways in the Parkinsonian Striatum.

about

Antidyskinetic Treatment with MTEP Affects Multiple Molecular Pathways in the Parkinsonian Striatum.

Item

http://www.wikidata.org/entity/Q47137434

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Antidyskinetic Treatment with ...... in the Parkinsonian Striatum.

@en

Antidyskinetic Treatment with ...... in the Parkinsonian Striatum.

@nl

type

Item

label

Antidyskinetic Treatment with ...... in the Parkinsonian Striatum.

@en

Antidyskinetic Treatment with ...... in the Parkinsonian Striatum.

@nl

prefLabel

Antidyskinetic Treatment with ...... in the Parkinsonian Striatum.

@en

Antidyskinetic Treatment with ...... in the Parkinsonian Striatum.

@nl

P1476

Antidyskinetic Treatment with ...... s in the Parkinsonian Striatum

@en

P2093

Ai-Juan Yan

http://www.w3.org/2001/XMLSchema#string

Cheng-Long Xie

http://www.w3.org/2001/XMLSchema#string

Jing-Ya Lin

http://www.w3.org/2001/XMLSchema#string

Lu Song

http://www.w3.org/2001/XMLSchema#string

P2860

An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior

Metabotropic glutamate receptors: from the workbench to the bedside.

Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors.

L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function.

Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia.

Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling

A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys.

Interactions of CaMKII with dopamine D2 receptors: roles in levodopa-induced dyskinesia in 6-hydroxydopamine lesioned Parkinson's rats

Mechanisms of dopamine D1 receptor-mediated ERK1/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5.

L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission.

P304

5798734

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/5798734

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Zhen-Guo Liu

P577

2017-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29209553

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

corpus striatum

P932

5682907

http://www.w3.org/2001/XMLSchema#string